KATELIN WELSH: Open Payments
NPI 1679915383 · CONOVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $259 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $157 |
| Novo Nordisk Inc | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 1 | $52 |
| Exact Sciences Corporation | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Alvogen Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Amgen Inc. | 1 | $13 |
Products named: AIRSUPRA, KEVEYIS, Cologuard Collection Kit, Wegovy, Ozempic, Kerendia, TERIPARATIDE, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
